CME
- Website
- http://reachmd.com/cme/
- Description
- Language
- 🇬🇧 English
- last modified
- 2025-02-20 22:45
- last episode published
- 2025-01-31 00:00
- publication frequency
- 2.18 days
- Contributors
- ReachMD
- Author Owner
- Explicit
- false
- Number of Episodes
- 2765
- Rss-Feeds
- Detail page
- Categories
- Medicine Science & Medicine Health & Fitness
Recommendations
Episodes
| Date | Title & Description | Contributors |
|---|---|---|
| 2025-01-31 |
No Patient Left Behind! Advancing CKD-Associated Pruritus Care Host: Kieran McCafferty, MD Guest: Maurizio Gallieni, MD Patients with chronic kidney disease-associated pruritus (CKD-aP) often face delays in diagnosis and treatment, as well as potential side effects from some prescribed medicines. Tun... |
|
| 2025-01-24 |
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis, and Management Host: Saurabh Malhotra, MD, MPH Guest: Kevin Alexander, MD Guest: Tawfiq Al-lahham, MD Guest: Sarah Cuddy, MD Guest: Angela Dispenzieri, MD Guest: Anita D’Souza, MD Guest: Foluso Fakorede, MD Guest: Mazen Hanna, MD Guest... |
|
| 2025-01-17 |
Beyond the Symptoms: The True Impact of gMG on Patients' Lives Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |
|
| 2025-01-17 |
Understanding Disease Progression: The Shift From Ocular to Generalized MG Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |
|
| 2025-01-17 |
Life-Threatening Events: Understanding and Preventing Myasthenic Crisis Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |
|
| 2025-01-17 | Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... | |
| 2025-01-17 | Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... | |
| 2025-01-17 |
Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |
|
| 2025-01-17 |
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |
|
| 2025-01-17 |
FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy Guest: Nicholas J. Silvestri, MD, FAAN Guest: James F. Howard, Jr, MD The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bri... |